These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 27879559)

  • 21. Angiotensin for septic shock unresponsive to noradrenaline.
    Yunge M; Petros A
    Arch Dis Child; 2000 May; 82(5):388-9. PubMed ID: 10799431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vasopressor Therapy in the Intensive Care Unit.
    Russell JA; Gordon AC; Williams MD; Boyd JH; Walley KR; Kissoon N
    Semin Respir Crit Care Med; 2021 Feb; 42(1):59-77. PubMed ID: 32820475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vasopressin and terlipressin in neonates and children with refractory septic shock.
    Biban P; Gaffuri M
    Curr Drug Metab; 2013 Feb; 14(2):186-92. PubMed ID: 23439212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vasopressor and Inotrope Therapy in Cardiac Critical Care.
    Jentzer JC; Hollenberg SM
    J Intensive Care Med; 2021 Aug; 36(8):843-856. PubMed ID: 32281470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel Vasopressors in the Treatment of Vasodilatory Shock: A Systematic Review of Angiotensin II, Selepressin, and Terlipressin.
    Rodriguez R; Cucci M; Kane S; Fernandez E; Benken S
    J Intensive Care Med; 2020 Apr; 35(4):327-337. PubMed ID: 30563433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of continuous vasopressin infusion in patients with septic shock.
    Obritsch MD; Jung R; Fish DN; MacLaren R
    Ann Pharmacother; 2004; 38(7-8):1117-22. PubMed ID: 15178740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of terlipressin in pediatric septic shock: a review of the literature and personal experience.
    Papoff P; Mancuso M; Barbara CS; Moretti C
    Int J Immunopathol Pharmacol; 2007; 20(2):213-21. PubMed ID: 17624234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of vasopressin in the management of septic shock.
    Mutlu GM; Factor P
    Intensive Care Med; 2004 Jul; 30(7):1276-91. PubMed ID: 15103461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of hypotension in septic shock.
    Pastor CM; Morel DR
    Lancet; 1996 Mar; 347(9001):622; author reply 622-3. PubMed ID: 8596355
    [No Abstract]   [Full Text] [Related]  

  • 30. Angiotensin II Infusion for Shock: A Multicenter Study of Postmarketing Use.
    Wieruszewski PM; Wittwer ED; Kashani KB; Brown DR; Butler SO; Clark AM; Cooper CJ; Davison DL; Gajic O; Gunnerson KJ; Tendler R; Mara KC; Barreto EF
    Chest; 2021 Feb; 159(2):596-605. PubMed ID: 32882250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Catecholamine Vasopressor Support Sparing Strategies in Vasodilatory Shock.
    Buckley MS; Barletta JF; Smithburger PL; Radosevich JJ; Kane-Gill SL
    Pharmacotherapy; 2019 Mar; 39(3):382-398. PubMed ID: 30506565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vasopressor weaning in patients with septic shock.
    Arellano DL; Hanneman SK
    Crit Care Nurs Clin North Am; 2014 Sep; 26(3):413-25. PubMed ID: 25169693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin II for the treatment of septic shock in a neutropenic patient with T-cell acute lymphoblastic leukaemia.
    Bui AD; Helgeson SA; Guru PK; Sanghavi DK
    BMJ Case Rep; 2020 Jun; 13(6):. PubMed ID: 32595128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin II (Giapreza): A Distinct Mechanism for the Treatment of Vasodilatory Shock.
    Khalique SC; Ferguson N
    Cardiol Rev; 2019; 27(3):167-169. PubMed ID: 30601161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vasopressors in Sepsis.
    Colling KP; Banton KL; Beilman GJ
    Surg Infect (Larchmt); 2018; 19(2):202-207. PubMed ID: 29336676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vasopressor use in septic shock: an update.
    Leone M; Martin C
    Curr Opin Anaesthesiol; 2008 Apr; 21(2):141-7. PubMed ID: 18443479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of equipressor doses of norepinephrine, epinephrine, and phenylephrine on septic myocardial dysfunction.
    Ducrocq N; Kimmoun A; Furmaniuk A; Hekalo Z; Maskali F; Poussier S; Marie PY; Levy B
    Anesthesiology; 2012 May; 116(5):1083-91. PubMed ID: 22407285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacologic Agents for the Treatment of Vasodilatory Shock.
    Knotzer H; Poidinger B; Kleinsasser A
    Curr Pharm Des; 2019; 25(19):2133-2139. PubMed ID: 31272348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multimodal strategy to counteract vasodilation in septic shock.
    Leone M; Einav S; Antonucci E; Depret F; Lakbar I; Martin-Loeches I; Wieruszewski PM; Myatra SN; Khanna AK
    Anaesth Crit Care Pain Med; 2023 Jun; 42(3):101193. PubMed ID: 36621622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Norepinephrine in septic shock: when and how much?
    Hamzaoui O; Scheeren TWL; Teboul JL
    Curr Opin Crit Care; 2017 Aug; 23(4):342-347. PubMed ID: 28509668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.